Better liver test for metabolic fatty liver disease
Part of Digestive system clinical trials.
This study tests a better way to check for advanced liver scarring (cirrhosis) in people with fatty liver disease. It might help you avoid unnecessary procedures if you have metabolic liver disease and are at risk of serious liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with a fatty liver or metabolic liver disease (like diabetes or obesity).
- You had a FibroScan (special ultrasound) that showed your liver stiffness score is 10 or higher.
- You had an upper endoscopy (camera test for your esophagus and stomach) within the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two non-invasive approaches to diagnose advanced liver scarring in people with non-alcohol-related fatty liver disease (NAFLD). It may help confirm which test strategy finds advanced scarring without needing a biopsy for everyone.
This study tests a way to find liver scarring (fibrosis) early in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. Early detection may help prevent serious liver damage.
This study is for people with NASH and moderate-to-advanced liver scarring (fibrosis). Researchers want to see if they can better measure how the scarring changes over time using a liver biopsy.
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.